USD 14.25
(1.75%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 | 52.14 Billion JPY | 6.17% |
2023 | 49.12 Billion JPY | -8.73% |
2022 | 53.81 Billion JPY | -0.41% |
2021 | 54.04 Billion JPY | 17.46% |
2020 | 46.01 Billion JPY | -14.2% |
2019 | 53.62 Billion JPY | 10.5% |
2018 | 48.53 Billion JPY | -0.79% |
2017 | 48.91 Billion JPY | 4.97% |
2016 | 46.59 Billion JPY | -1.8% |
2015 | 47.45 Billion JPY | 11.9% |
2014 | 42.4 Billion JPY | 4.59% |
2013 | 40.54 Billion JPY | 28.75% |
2012 | 31.49 Billion JPY | 4.28% |
2011 | 30.2 Billion JPY | 0.5% |
2010 | 30.05 Billion JPY | 11.67% |
2009 | 26.91 Billion JPY | -6.61% |
2008 | 28.81 Billion JPY | 6.6% |
2007 | 27.03 Billion JPY | -2.17% |
2006 | 27.63 Billion JPY | 2.11% |
2005 | 27.06 Billion JPY | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 46.68 Billion JPY | -0.37% |
2024 Q1 | 46.85 Billion JPY | -4.61% |
2024 Q4 | 52.14 Billion JPY | 17.69% |
2024 Q3 | 44.3 Billion JPY | -5.09% |
2024 FY | 52.14 Billion JPY | 6.16% |
2023 FY | 49.12 Billion JPY | -8.73% |
2023 Q1 | 46.66 Billion JPY | -13.3% |
2023 Q2 | 46.86 Billion JPY | 0.44% |
2023 Q4 | 49.12 Billion JPY | 9.72% |
2023 Q3 | 44.76 Billion JPY | -4.48% |
2022 Q1 | 40.98 Billion JPY | -24.16% |
2022 FY | 53.81 Billion JPY | -0.41% |
2022 Q3 | 41.8 Billion JPY | -1.89% |
2022 Q2 | 42.6 Billion JPY | 3.96% |
2022 Q4 | 53.81 Billion JPY | 28.74% |
2021 Q2 | 41.66 Billion JPY | 4.71% |
2021 Q4 | 54.04 Billion JPY | 26.29% |
2021 Q1 | 39.78 Billion JPY | -13.53% |
2021 FY | 54.04 Billion JPY | 17.46% |
2021 Q3 | 42.79 Billion JPY | 2.71% |
2020 FY | 46.01 Billion JPY | -14.2% |
2020 Q2 | 39.73 Billion JPY | -2.88% |
2020 Q1 | 40.91 Billion JPY | -23.71% |
2020 Q4 | 46.01 Billion JPY | 27.31% |
2020 Q3 | 36.14 Billion JPY | -9.05% |
2019 FY | 53.62 Billion JPY | 10.5% |
2019 Q2 | 40.85 Billion JPY | -2.35% |
2019 Q1 | 41.83 Billion JPY | -13.84% |
2019 Q4 | 53.63 Billion JPY | 25.53% |
2019 Q3 | 42.72 Billion JPY | 4.57% |
2018 Q4 | 48.55 Billion JPY | 18.93% |
2018 FY | 48.53 Billion JPY | -0.79% |
2018 Q3 | 40.83 Billion JPY | 3.29% |
2018 Q2 | 39.52 Billion JPY | -6.0% |
2018 Q1 | 42.05 Billion JPY | -14.04% |
2017 Q4 | 48.92 Billion JPY | 24.14% |
2017 Q3 | 39.4 Billion JPY | 4.09% |
2017 Q2 | 37.85 Billion JPY | -3.14% |
2017 FY | 48.91 Billion JPY | 4.97% |
2017 Q1 | 39.08 Billion JPY | -16.13% |
2016 FY | 46.59 Billion JPY | -1.8% |
2016 Q2 | 34.07 Billion JPY | -9.82% |
2016 Q1 | 37.79 Billion JPY | -20.36% |
2016 Q3 | 36.12 Billion JPY | 5.99% |
2016 Q4 | 46.6 Billion JPY | 29.02% |
2015 Q2 | 36.67 Billion JPY | 12.38% |
2015 FY | 47.45 Billion JPY | 11.9% |
2015 Q4 | 47.45 Billion JPY | 24.65% |
2015 Q1 | 32.63 Billion JPY | -23.06% |
2015 Q3 | 38.06 Billion JPY | 3.81% |
2014 Q1 | 35.06 Billion JPY | -13.51% |
2014 FY | 42.4 Billion JPY | 4.59% |
2014 Q4 | 42.4 Billion JPY | 29.71% |
2014 Q3 | 32.69 Billion JPY | -0.2% |
2014 Q2 | 32.76 Billion JPY | -6.58% |
2013 Q4 | 40.54 Billion JPY | 26.33% |
2013 Q3 | 32.09 Billion JPY | 9.06% |
2013 Q1 | 28.76 Billion JPY | -8.65% |
2013 FY | 40.54 Billion JPY | 28.75% |
2013 Q2 | 29.42 Billion JPY | 2.29% |
2012 Q4 | 31.49 Billion JPY | 22.46% |
2012 Q1 | 24.82 Billion JPY | -17.82% |
2012 Q2 | 25.49 Billion JPY | 2.72% |
2012 Q3 | 25.71 Billion JPY | 0.86% |
2012 FY | 31.49 Billion JPY | 4.28% |
2011 Q4 | 30.2 Billion JPY | 17.79% |
2011 FY | 30.2 Billion JPY | 0.5% |
2011 Q1 | 24.87 Billion JPY | -17.24% |
2011 Q2 | 25.53 Billion JPY | 2.68% |
2011 Q3 | 25.64 Billion JPY | 0.4% |
2010 Q4 | 30.05 Billion JPY | 20.77% |
2010 Q3 | 24.88 Billion JPY | 6.87% |
2010 Q2 | 23.28 Billion JPY | 0.0% |
2010 FY | 30.05 Billion JPY | 11.67% |
2009 Q3 | 24.73 Billion JPY | 0.0% |
2009 Q4 | 26.91 Billion JPY | 8.81% |
2009 FY | 26.91 Billion JPY | -6.61% |
2008 FY | 28.81 Billion JPY | 6.6% |
2007 FY | 27.03 Billion JPY | -2.17% |
2006 FY | 27.63 Billion JPY | 2.11% |
2005 FY | 27.06 Billion JPY | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
QHSLab, Inc. | 2.05 Million USD | -2534987.886% |
Rafina Innovations Inc. | - USD | -Infinity% |
Aurora Spine Corporation | 6.65 Million USD | -783663.701% |
ADM Tronics Unlimited, Inc. | 1.44 Million USD | -3605422.088% |
Avitar, Inc. | 11.59 Million USD | -449702.373% |
Bionovate Technologies Corp | - USD | -Infinity% |
Escalon Medical Corp. | 2.94 Million USD | -1768622.296% |
Manhattan Scientifics, Inc. | 2.11 Million USD | -2462034.089% |
Össur hf. | 688.8 Million USD | -7470.782% |
Össur hf. | 688.8 Million USD | -7470.782% |
CVR Medical Corp. | - USD | -Infinity% |
Stratec SE | 271.97 Million USD | -19074.149% |
Vycor Medical, Inc. | 4.31 Million USD | -1207651.957% |
BrainsWay Ltd. | 15.31 Million USD | -340425.01% |
Kelyniam Global, Inc. | 1.01 Million USD | -5148107.93% |
Lattice Biologics Ltd. | - USD | -Infinity% |
Positron Corporation | 2.02 Million USD | -2573841.337% |
Wellstar International, Inc. | 55.99 Million USD | -93037.152% |
Vivos Inc. | 245 Thousand USD | -21284450.456% |
Nexeon MedSystems Inc. | 8.48 Million USD | -614674.85% |
Heart Tronics, Inc. | 1.09 Million USD | -4763192.287% |
REMSleep Holdings, Inc. | 275.61 Thousand USD | -18920564.407% |
AVITA Medical, Inc. | 19.86 Million USD | -262406.63% |
Theraclion SA | 13.01 Million EUR | -400527.846% |
Hamilton Thorne Ltd. | 45.84 Million USD | -113653.892% |
BioElectronics Corporation | 16.62 Million USD | -313613.562% |
Zecotek Photonics Inc. | 5.86 Million USD | -888492.623% |
EKF Diagnostics Holdings plc | 16.08 Million USD | -324192.693% |
Nanomix Corporation | 14.81 Million USD | -351900.611% |
Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
Wellness Center USA, Inc. | 5.12 Million USD | -1017581.405% |
NewCardio, Inc. | 6.01 Million USD | -867205.199% |
Electromedical Technologies, Inc. | 3.62 Million USD | -1439987.044% |
Lombard Medical, Inc. | 53.79 Million USD | -96840.179% |
ALR Technologies Inc. | 24.5 Million USD | -212702.424% |
Nu-Med Plus, Inc. | 2.35 Million USD | -2210698.267% |
MicroPort Scientific Corporation | 2.48 Billion USD | -1997.339% |
VMS Rehab Systems, Inc. | 201.36 USD | -25897894218.633% |
Guided Therapeutics, Inc. | 5.47 Million USD | -952374.886% |
Ingen Technologies, Inc. | 5.7 Million USD | -913247.416% |
CYduct Diagnostics, Inc. | 2.44 Million USD | -2128556.613% |
Odyssey Group International, Inc. | 6.61 Million USD | -788620.397% |
SANUWAVE Health, Inc. | 65.59 Million USD | -79401.175% |
IR-Med Inc. | 634 Thousand USD | -8225136.593% |
Perimeter Medical Imaging AI, Inc. | 5.47 Million USD | -952102.53% |
United American Healthcare Corporation | 119 Thousand USD | -43821748.739% |
Polarean Imaging plc | 2.58 Million USD | -2020718.131% |
ECGI Holdings, Inc. | 11.94 Million USD | -436637.214% |
Capital Group Holdings, Inc. | 1.32 Million USD | -3938618.293% |
Medical Supply International USA, Inc. | 677.61 Thousand USD | -7695704.113% |
Rapid Therapeutic Science Laboratories, Inc. | 5.39 Million USD | -966308.287% |
SS Innovations International, Inc. | 11.18 Million USD | -466294.1% |
Urologix, Inc. | 12.64 Million USD | -412332.774% |
Qualis Innovations, Inc. | 525.38 Thousand USD | -9925535.769% |
Smith & Nephew plc | 4.76 Billion USD | -994.795% |
NIOX Group Plc | 9.8 Million USD | -531908.447% |
Fuse Medical, Inc. | 15.11 Million USD | -345020.951% |
Broncus Holding Corporation | 10.43 Million USD | -499776.919% |
Brain Scientific Inc. | 7.42 Million USD | -702097.282% |
Pressure BioSciences, Inc. | 33.8 Million USD | -154168.026% |
Health Logic Interactive Inc. | 794.08 Thousand USD | -6566988.244% |